Abstract
Objective. ATB 0,+ is an energy-coupled transporter for arginine and amino acid-based prodrugs. The objective of the study was to examine the expression of this transporter in cervical cancer. Methods. Specimens of normal ectocervical mucosa and cervical squamous cell carcinoma were used for determination of ATB 0,+ mRNA levels by RT-PCR. A commercial dot blot of paired normal cervix and cervical cancer cDNA was also used to quantify ATB 0,+ mRNA. ATB 0,+ mRNA and protein in tissue sections were analyzed by in situ hybridization and immunohistochemistry/immunofluorescence. Results. ATB 0,+ mRNA increased 5.6-fold ( P < 0.0004) in cervical cancer compared to normal cervix. This was associated with a parallel increase in ATB 0,+ protein. Conclusions. Expression of ATB 0,+ is minimal in normal cervix and is up-regulated in cervical cancer. The up-regulation of this highly concentrative transporter for arginine and prodrugs in cervical cancer has significant clinical and therapeutic relevance.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
